RASTAGENE BIOPHARMACEUTICAL CO

Business Type: Manufacturer (Factory)

Company Profile:

Rastagene Biopharmaceutical is a prominent Iranian biotechnology company specializing in the research, development, and manufacturing of advanced biopharmaceutical products. The company focuses on the production of high-quality recombinant proteins, therapeutic antibodies, and specialized pharmaceutical formulations. Operating state-of-the-art manufacturing facilities that adhere to international GMP standards, Rastagene is dedicated to advancing local healthcare capabilities through innovation in biotechnology and clinical research. Their operations encompass the entire value chain from laboratory-scale development to large-scale industrial production, positioning them as a key player in the Iranian pharmaceutical industry.

Rastagene Biopharmaceutical Co. specializes in the production and supply of the following pharmaceutical and biotechnology products:

Product Categories:

1. Oncology Medications

- Doxorubicin Hydrochloride Liposomal Injection

- Docetaxel Injection

- Paclitaxel Injection

- Gemcitabine Hydrochloride Injection

- Oxaliplatin Injection

2. Supportive Care and Specialized Therapies

- Zoledronic Acid Injection

- Irinotecan Hydrochloride Injection

- Epirubicin Hydrochloride Injection

3. Biotechnology and Biosimilars

- Recombinant therapeutic proteins

- Monoclonal antibodies for cancer treatment

4. Raw Materials and APIs

- Active Pharmaceutical Ingredients (APIs) for oncology and complex injectable formulations

Note: The product portfolio may evolve based on regulatory approvals and manufacturing capacity. This list reflects their primary focus on high-tech oncology and injectable pharmaceutical solutions.